Cellular
function of satellite cells does not play a role in muscle weakness of adult Ts1Cje
mice
Chai Ling Lim 1, Usman Bala 1,2,
Melody Pui-Yee Leong 3, Johnson Stanslas 4, Rajesh
Ramasamy 5,6, King-Hwa Ling 3,6 and Pike-See Cheah
1,6,*
1 Department of Human Anatomy, Faculty of Medicine and Health Sciences,
Universiti Putra Malaysia,
43400 UPM Serdang, Selangor, Malaysia.
2 Department of Human Anatomy, College of Medical Sciences, Gombe State
University, Gombe, Nigeria.
3 Department of Biomedical Science, Faculty of Medicine and Health
Sciences, Universiti Putra Malaysia,
43400 UPM Serdang, Selangor, Malaysia.
4 Department of Medicine, Faculty of Medicine and Health Sciences,
Universiti Putra Malaysia,
43400 UPM Serdang, Selangor, Malaysia.
5 Department of Pathology, Faculty of Medicine and Health Sciences,
Universiti Putra Malaysia,
43400 UPM Serdang, Selangor, Malaysia.
6 Genetics and Regenerative Medicine Research Centre, Faculty of Medicine
and Health Sciences,
Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.
* Correspondence: cheahpikesee@upm.edu.my; Tel.: +603-8947-2355
Received: 10 March 2018; Accepted: 11 May 2018; Published: 15 May 2018
Edited by: Noraishah Mydin
Abdul-Aziz (University of Malaya, Malaysia)
Reviewed by: Thilakavathy
Karuppiah (Universiti Putra Malaysia, Malaysia); Meow-Keong Thong (University
of Malaya, Malaysia)
DOI: https://doi.org/10.31117/neuroscirn.v1i1.6
ABSTRACT: Down
syndrome (DS) is a genetic condition resulting from triplication of human
chromosome (HSA)21. Besides intellectual disability, DS is frequently
associated with hypotonia. Satellite cells are the resident cells that provides
robust and remarkable regenerative capacity to the skeletal muscles, and its
population size has been reported to be disease-associated. However, little is known about the
population size of satellite cells in DS and the association of its intrinsic
cellular functionality and hypotonia seen in DS. Here, we studied the Ts1Cje
mouse, a DS murine model displays the muscle weakness characteristic. Satellite
cell populations were immunostained with Pax7 and myonuclei numbers in the
Ts1Cje extensor digitorum longus muscle were assessed. Their cellular function
was further determined via in vitro
assay in high-serum conditioned medium. Subsequently, the in vitro self-renewal, proliferative, and differentiation
activities of these myogenic precursor cells were assessed after 24, 48, and
72h using Pax7, MyoD, and Ki67 immunomarkers. Our results showed that the
population and functionality of Ts1Cje satellite cell did not differ
significantly when compared to the wildtype cells isolated from disomic
littermates. In conclusion, our findings indicated that intrinsic cellular
functionality of the satellite cells, do not contribute to muscle weakness in
Ts1Cje mouse.
Keywords:
Down
syndrome; skeletal muscle; stem cells; muscle weakness; satellite cells
©2018
by Lim et al for use and distribution in accord with the Creative Commons Attribution
(CC BY-NC 4.0) license (https://creativecommons.org/licenses/by-nc/4.0/), which permits
unrestricted non-commercial use, distribution, and reproduction in any medium,
provided the original author and source are credited.
1. INTRODUCTION
Down syndrome (DS) is a chromosomal
condition caused by trisomy of human chromosome 21 (HSA21), which occurs at a
rate of approximately 1 in every 700 live births worldwide [1-2]. The extra copy of chromosome 21 caused the
imbalance expression of HSA21 and non-HSA21 genes, and eventually leads to
various phenotypic features in DS individuals such as cognitive impairment,
craniofacial abnormalities and hypotonia.
Hypotonia
is a state of low muscle tone accompanied by a slower response speed together
with reduced muscle strength [3-4]. Cowley et al. [5] reported that the
force generated by the knee extensor muscle of DS individuals is approximately
40%-70% less than that generated by individuals with intellectual disabilities
other than DS and those with normal intellectual ability.
Satellite
cells are rare mononuclear cells with a low cytoplasmic content that are wedged
between the basal lamina and sarcolemma of postnatal skeletal muscle [6]. In
adult skeletal muscle, satellite cells are mitotically quiescent under normal
circumstances and become activated in response to exercise and muscle injury [7].
Activated satellite cells, identified by their expression of myogenic
regulatory factor MyoD, transiently re-enter the cell cycle to proliferate and
subsequently exit the cell cycle to differentiate or self-renew [8].
Hence, satellite cells play an essential role in skeletal muscle regeneration
and maintenance of homeostasis [9]. It is hypothesized that a small defect in
satellite cells can lead to a series of complications in recurrent
regeneration. Many studies have reported that impairment of satellite cells is
responsible for the pathogenesis of many muscular diseases [10-11]. Unfortunately, only limited information on the population size of the
satellite cells in DS skeletal muscle and in exploring their role in muscle
weakness seen in animal models of DS.
In
this study, Ts1Cje mouse model of DS, also known as T(12;16)1Cje [12] was used to identify possible mechanisms involved in DS-associated
hypotonia, focusing on characterization of the population size and cellular
function of satellite cells isolated from Ts1Cje mouse skeletal muscles. The
Ts1Cje mouse displays a remarkable number of phenotypic characteristics reminiscent
of those commonly observed among DS individuals, including structural and
cognitive alterations of the brain, craniofacial alterations and congenital
heart defects [13]. Recent studies reported that Ts1Cje display reduced grip strength and
locomotor activity compared to disomic/wildtype (WT) littermates [14]. Thus, Ts1Cje mice have considerable value in studies investigating
the mechanisms of DS-associated pathology.
2. MATERIALS
AND METHODS
2.1 Animals and ethics
statement
This study was approved by the
Institutional Animal Care and Use Committee (IACUC), Universiti Putra Malaysia
(UPM) (Reference number: UPM/IACUC/AUP-R003/2014). Adult disomic C57BL/6 mice
(WT/control) and adult trisomic Ts1Cje mice at postnatal days (P) 56-70 were
used. They were generated by mating male Ts1Cje mice with female C57BL/6 mice,
and their genotypes were determined by tail genotyping as described previously
[12,15]. All mice were
bred under controlled environmental conditions with a 12-h light/12-h dark
cycle at 21-23oC and 55% relative humidity. Food and water
were available ad libitum with a standard pellet diet. All mice were euthanized
by cervical dislocation after being anesthetized in a chamber containing 2.5%
isoflurane in 100% oxygen.
2.2 Single
myofiber isolation, immunostaining, and analysis
The extensor digitorum longus
(EDL) muscle from adult Ts1Cje mice (n = 9; 4 males, 5 females) and age-matched
control littermates (n = 9; 4 males, 5 females) were harvested using a
tendon-to-tendon approach. Single myofibers were isolated as described
previously [16]. The satellite cells were
immunostained with Pax7 (1:5; Developmental Studies Hybridoma Bank, Iowa City,
USA), while the myonuclei were counterstained with 4,
6-diamidino-2-phenylindole (DAPI). Subsequently, fluorescence microscopic
images were acquired using an Olympus BX51 fluorescence microscope (Olympus,
Tokyo, Japan) equipped with an UPlanF1 objective lens with Olympus ANALYSIS®
FIVE acquisition software. Further
image processing was achieved using ImageJ software (http://rsbweb.nih.gov/ij/). Satellite cells and
myonuclei were counted manually in images captured at 10X magnification with
the aid of ImageJ to determine the number of each myofiber. Student's t-test was performed to test
for significant differences between the two genotypes. This experiment was
conducted on 20 isolated EDL myofibers per replicate and biological triplicates
for each genotype (e.g., a total of ≥80 collected myofibers per genotype).
2.3 Primary
myoblasts isolation, culture, immunostaining and analysis
The EDL of six adult male mice
(n = 3 per genotype) was harvested and digested in 0.2% (w/v) collagenase type
I solution at 37oC for 60 min. The cells were pelleted by
centrifuged at 300g for 5 minutes at 16oC. The cell pellet
was resuspended in 0.05% Trypsin-EDTA (Gibco, Paisley, UK), and serial
trituration was subsequently performed using pipettes with different bore sizes
(from 10-ml serological pipette, 5-ml serological pipette, 1-ml pipette tip to
18 G needle attached to a 1-ml syringe). The satellite cell-trypsin mixture was
then incubated at 37oC for 10 min, centrifuged at 300g for 10 min at
16oC. The cell pellet was
resuspended in conditioned medium [DMEM containing sodium pyruvate, 20% fetal
bovine serum (Gibco), 10% horse serum (Hyclone, Logan, UT, USA), 1% chick
embryonic extract (Gemini Bio Products, West Sacramento, CA, USA), and 1%
penicillin-streptomycin (Gibco)] and filtered through a 40 µm nylon cell
strainer (Corning Incorporated, Corning, NY, USA). The cell suspension was preplated in
uncoated T-75 tissue culture flask (Techno Plastic Products, Trasadingen,
Switzerland) for 2 h. After preplating, the purified cells were cultured in the
10% Matrigel®-coated 24-well plastic tissue culture plates (Techno Plastic
Products).
When the primary myoblasts
culture reached 75% confluency, they were trypsinised and seeded on 8-well
removable micro-chamber slip (Ibidi USA, Madison, WI, USA) at a density of
1,000 cells/well in conditioned medium. The primary myoblast cultures were
subsequently fixed and subjected to double immunocytochemical staining. In brief,
the cells were fixed with 4% (w/v) paraformaldehyde (pH 7.4) in PBS for 10 min,
permeabilized with 0.5% (v/v) Triton X-100 for 8 min and blocked with 1X PBS
containing 1% (v/v) goat serum (Gibco) overnight at 4oC. The cells were
incubated with primary antibody for overnight at 4oC then with
secondary antibody for 1 h at room temperature followed by mounting in ProLong®
Gold Antifade Reagent (Invitrogen, Carlsbad, CA, USA) containing DAPI.
Self-renewing, proliferating, and differentiating myoblast progeny were
distinguished as Pax7+MyoD-, Pax7+MyoD+ and Pax7-MyoD+, respectively [17]. Myoblast proliferation and differentiation were confirmed using the
cell proliferation marker Ki67 [18] combined with the
myogenic marker MyoD. Proliferating and differentiating myoblast progeny were
distinguished as Ki67+MyoD+ (proliferating) and Ki67-MyoD+ (differentiating).
Primary antibodies used were mouse monoclonal anti-Pax7 (1:5; clone Pax7;
Developmental Studies Hybridoma Bank, Iowa City, IA, USA), mouse monoclonal
anti-MyoD (1:200; clone 5.8A; Thermo Fisher Scientific, Inc., MA, USA), and
rabbit polyclonal anti-MyoD (1:200; Santa Cruz Biotechnology, Santa Cruz, CA,
USA).
Fluorescent microscope images
were acquired then processed and assembled into figures using ImageJ (http://rsbweb.nih.gov/ij/). The number of
progeny from each different group was counted manually in images captured at
20X magnification using ImageJ. The self-renewal, proliferation and
differentiation indices of progeny were determined by calculating the mean
percentage of Pax7+MyoD- (self-renewing); Pax7+MyoD+ and Ki67+MyoD+
(proliferating) and Pax7-MyoD+ and Ki67-MyoD+ (differentiating) progeny in at
least 200 cells. Significant differences between Ts1Cje and WT controls were
determined using Student's t-test. A minimum of three replicates were analyzed
for each experiment.
3. RESULTS
3.1 Assessment
of satellite cell populations and myonuclei number in skeletal muscle of Ts1Cje
mice
Associated satellite cells
were quantified by Pax7 immunostaining (a marker for quiescent satellite
cells), and all myonuclei were counterstained with DAPI (Figure 1a). The
corresponding results showed no significant differences (P > 0.05) in the
number of Pax7-
expressing satellite cells per
myofiber between the two genotypes in both male (WT = 7.73 ± 0.8; Ts1Cje = 6.97
± 0.6; n = 4; P = 0.5845) and female (WT = 4.75 ± 0.6; Ts1Cje = 4.76 ± 0.5; n =
5; P = 0.9883) groups, suggesting there are no differences in the satellite
cell pools between both genotypes and genders (Figure 1b).
To further investigate the
size of myofibers, the average number of myonuclei present in each myofiber was
assessed. The results showed there was no significant difference (P > 0.05)
in the average number of myonuclei present in each myofiber of the two
genotypes for both genders (male: WT = 268.70 ± 9, Ts1Cje = 253.83 ± 11, n = 4,
P = 0.4572; female: WT = 233 ± 8, Ts1Cje = 213.59 ± 8, n = 5, P = 0.2844;
Figure 1c). These data suggest that Ts1Cje mouse myofibers are similar in size
to those of WT mice. Taken together, normal satellite cell pool size and
myonuclear populations are present in the Ts1Cje mouse skeletal muscle.
Figure 1. Analysis
of the satellite cells and myonuclei in the trisomic Ts1Cje skeletal muscle.
(a) Isolated single myofibres immunostained with (i) Pax7 and (ii) DAPI show
satellite cell and myonuclei. Scale bar 2000µm. Student t-test revealed both
(b) average number of satellite cells and (c) average number of myonuclei in
each myofiber did not differ significantly between the two genotypes for both
genders. In vitro cellular function
analysis also demonstrated that the (d) Pax7+MyoD--self-renewing, (e) Pax7+MyoD+-proliferating
and (f) Pax7-MyoD+ -differentiating population of satellite cells were not
statistically significant between the two genotypes across the 24, 48 and 72
consecutive hours of assessment.
3.2 Assessment
of the cellular function of satellite cells from Ts1Cje mouse skeletal muscle
The self-renewal efficiency of
satellite cells was also assessed in this experiment. The Pax7+MyoD-
(self-renewing) satellite cells of the Ts1Cje culture (24 h: 1.27 ± 0.34%; 48
h: 1.41 ± 0.41%; 72 h: 1.37 ± 0.40%) was consistently lower than the WT control
(24 h: 2.17 ± 0.49%; 48 h: 1.98 ± 0.44%; 72 h: 2.09 ± 0.41%), although not
statistically significant (24 h: P = 0.2136; 48 h: P = 0.3977; 72 h: P =
0.2725) (Figure 1d).
We found that the number of
Pax7+MyoD+ (proliferating) satellite cells in the WT control cultures (24 h:
78.62 ± 5.40%; 48 h: 68.09 ± 5.63%; 72 h: 31.68 ± 4.63%) was consistently higher
than the number of Pax7+MyoD+ satellite cells in the Ts1Cje culture (24 h:
70.58 ± 6.84%; 48 h: 57.08 ± 3.53%; 72 h: 24.47 ± 4.46%), although no
significant differences were found between the two genotypes (24 h: P = 0.4110;
48 h: P = 0.1863; 72 h: P = 0.3254; Figure 1e). These data agreed with that
obtained based on MyoD and Ki67 expression patterns, which also demonstrated
that there was no difference in proliferative potential of satellite cells
between the two genotypes (24 h: WT =
68.71 ± 6.14%, Ts1Cje = 58.70
± 5.69%, P = 0.4110; 48 h: WT = 50.42 ± 9.98%, Ts1Cje = 41.64 ± 6.30%, P =
0.5056; 72 h: WT = 38.54 ± 4.76%, Ts1Cje = 28.11 ± 7.62%, P = 0.3213; Figure
2a).
We also further assessed the
differentiation potential of satellite cells. Based on the data obtained at 24,
48 and 72 h after cell seeding. The percentage of Pax7-MyoD+ (differentiating)
satellite cells in the Ts1Cje culture (24 h: 18.57 ± 5.84%; 48 h: 25.50 ±
4.74%; 72 h: 34.30 ± 6.73%) was not significantly different to that of the WT
control culture (24 h: 11.68 ± 6.00%; 48 h: 15.50 ± 5.28%; 72 h: 37.20 ± 2.88%;
24 h: P = 0.4595; 48 h: P = 0.2328; 72 h: P = 0.7213; Figure 1f). Additionally,
similar results were obtained based on MyoD and Ki67 expression patterns
analysis, which also suggested that the differentiation potential was not
significantly different between the two genotypes across the 3 consecutive days
of evaluation (24 h: WT = 16.45 ± 8.47%, Ts1Cje = 23.02 ± 7.01%, P = 0.5834); (48
h: WT = 20.53 ± 9.43%, Ts1Cje = 31.91 ± 3.42%, P = 0.3346); (72 h: WT = 21.97 ±
4.89%, Ts1Cje = 19.02 ± 5.72%, P = 0.7158; Figure 2b).
Figure
2. Percentage
of proliferating and differentiating progenies of satellite cells. (a)
Ki67+MyoD+ proliferating satellite cells showed no significant difference
between two genotypes [24 h: WT = 68.71 ± 6.14%, Ts1Cje = 58.70 ± 5.69%, P =
0.2985; 48 h: WT = 50.42 ± 9.98%, Ts1Cje = 41.64 ± 6.30%, P = 0.5056; 72 h: WT=
38.54 ± 4.76%, Ts1Cje = 28.11 ± 7.62%, P = 0.3213]. (b) Ki67+MyoD-
differentiating satellite cells of Ts1Cje were not significantly different from
WT [24 h : WT = 16,45 ± 8.47%, Ts1Cje = 23.02 ± 7.01%,
P= 0.5834; 48 h : WT = 31.92 ± 3.42%, Ts1CJe = 57.08 ± 6.11%, P= 0.3346; 72 h :
WT = 21.97 ± 4.89%, Ts1Cje = 19.02 ± 5.72%, P= 0.7158].
4. DISCUSSION
Our current data shows that
both the satellite cell pools and the myonuclear populations present in the
Ts1Cje mouse skeletal muscle are similar to those of
WT. The myonuclear number often reflects the size of satellite cell populations
because satellite cells are the main source of myonuclei during early postnatal
muscle development and adult skeletal muscle regeneration [19-20]. As such, the satellite cell number is always
directly proportional to the myonuclei number present on myofibers. To the best
of our knowledge, this is the first study to profile these muscle cells in a DS
model.
The myonuclei number also
reveals the size of the myofiber. Based on the myonuclear domain hypothesis,
the nucleus-to-cytoplam ratio will remain constant during myofiber growth;
hence, any increase in myofiber size must occur via addition of new myonuclei
from satellite cell proliferation. In the current study, we found a normal
number of myonuclei present in Ts1Cje mouse myofibers, indicating that these
myofibers are comparable to that of WT mice. Even though this interpretation was
predicted based on the myonuclear domain hypothesis [21-22], it supports data from our recent study on myofiber cross-sections
[unpublished data]. In that study, the cell cross-sectional area and morphology
of the Ts1Cje mouse skeletal muscle were investigated. The results of that
study showed no significant difference in terms of the cell cross-sectional
area and morphology between the two genotypes [unpublished data].
The present in vitro analyses
revealed no significant differences of the functionality and populations of the
satellite cells derived from Ts1Cje mice and WT littermates, indicating that
the trisomic genes may exert minimal influence on the self-renewal,
proliferation and differentiation profiles of the satellite cells. These
results further suggest that the intrinsic cellular functionality of the DS
satellite cell is similar to that of the WT. This
finding is still less conclusive because the present experiments revealed only
the in vitro cellular functionality
of satellite cells and not the in vivo
skeletal muscle regeneration process. Skeletal muscle regeneration is a highly
synchronized process governed by both intrinsic and extrinsic regulatory cues
and is also tightly linked to the local and systemic metabolism of a biological
system [23-24]. Hence, further
studies to reveal the overall in vivo
skeletal muscle regeneration process of Ts1Cje mouse skeletal muscle are
necessary in the future.
5. CONCLUSIONS
Overall, we showed that the DS
skeletal muscle has similar satellite cell population and intrinsic cellular
functionality as the WT.
Acknowledgements: This work was
supported in part by funding from the Fundamental Research Grant Scheme
(04-01-15-1663FR) awarded to P-SC. C-LL was a recipient of the Malaysian
Ministry of Higher Education MyMaster scholarship. Monoclonal antibody, Pax7
was developed by A. Kawakami and obtained from the Developmental Studies
Hybridoma Bank developed under the auspices of the NICHD and maintained by the
Department of Biological Sciences, at the University of Iowa (Iowa City, IA,
USA).
Author
Contributions: All authors of this research paper have directly participated in the
planning, execution, or analysis of this study; CLL, K-HL, and P-SC designed
the experiments. C-LL, UB, and MP-YL performed experiments and analyzed the
data. IKSY, JS, and RR co-supervised experimentation. CLL, K-HL and P-SC
drafted the manuscript.
Conflicts
of Interest: The authors declare no conflict of interest.
References
1. Roper R.J., Reeves R.H. Understanding the basis for
Down syndrome phenotypes. PLoS Genet 2006, 2: e50. https://doi.org/10.1371/journal.pgen.0020050
2. National Center on Birth Defects and Developmental
Disabilities (NCBDDD) | CDC. National Center on Birth Defects and
Developmental Disabilities Home | NCBDDD | CDC. 2017. Available at: http://www.cdc.gov/ncbddd/birthdefects/downsyndrome.html. Accessed May 26, 2017.
3. Brault V., Duchon A.,
Romestaing C., Sahun I., Pothion S., Karout M., et al. Opposite phenotypes of muscle strength and locomotor
function in mouse models of partial trisomy and monosomy 21 for the proximal
Hspa13-App region. PLOS Genet 2015, 11: e1005062. https://doi.org/10.1371/journal.pgen.1005062
4. Lisi E.C., Cohn R.D. Genetic
evaluation of the pediatric patient with hypotonia: perspective from a
hypotonia specialty clinic and review of the literature. Dev Med Child Neurol 2011,
53: 586-599. https://doi.org/10.1111/j.1469-8749.2011.03918.x
5. Cowley P.M., Keslacy S.,
Middleton F.A., DeRuisseau L.R., Fernhall B., Kanaley J.A., DeRuisseau K.C.
Functional and biochemical characterization of soleus muscle in Down syndrome
mice: insight into the muscle dysfunction seen in the human condition. Am J Physiol Regul Integr Comp Physiol 2012, 303: R1251-R1260. https://doi.org/10.1152/ajpregu.00312.2012
6. Yin H., Price F., Rudnicki M.
Satellite cells and the muscle stem cell niche. Physiol Rev 2013, 93: 23-67.
https://doi.org/10.1152/physrev.00043.2011
7. Boldrin L., Morgan J.E. Human satellite cells:
identification on human muscle fibres. PLoS Curr 2013, 3: RRN1294. https://doi.org/10.1371/currents.RRN1294
8. Dumont N.A., Wang Y.X.,
Rudnicki M.A. Intrinsic and extrinsic mechanisms regulating satellite cell
function. Development 2015, 142: 1572-1581.
https://doi.org/10.1242/dev.114223
9. Tierney M.T., Sacco A. The
role of muscle stem cell-niche interactions during aging. Nat Med 2016, 22: 837-838.
https://doi.org/10.1038/nm.4159
10. Shefer G., Van de Mark D.P.,
Richardson J.B., Yablonka-Reuveni Z. Satellite-cell pool size does matter:
Defining the myogenic potency of aging skeletal muscle. Dev Biol 2006, 294: 50-66.
https://doi.org/10.1016/j.ydbio.2006.02.022
11. Shefer G., Rauner G., Yablonka-Reuveni
Z., Benayahu D. Reduced satellite cell numbers and myogenic capacity in aging
can be alleviated by endurance exercise. PLoS
ONE 2010, 5: e13307. https://doi.org/10.1371/journal.pone.0013307
12. Sago H., Carlson E., Smith D.,
Kilbridge J., Rubin E., Mobley W.C., Epstein C.J., Huang T.T. Ts1Cje, a partial trisomy 16 mouse model
for Down syndrome, exhibits learning and behavioral abnormalities. Proc Natl Acad Sci USA 1998, 95: 6256-6261. https://www.ncbi.nlm.nih.gov/pubmed/9600952
13. Liu B., Filippi S., Roy A.,
Roberts I. Stem and progenitor cell dysfunction in human trisomies. EMBO Rep 2015, 16: 44-62. https://doi.org/10.15252/embr.201439583
14.
Shimohata A., Ishihara K., Hattori S., Miyamoto H., Morishita H., Ornthanalai G., Raveau M., Ebrahim A.S., Amano K., Yamada K., Sago H., Akiba S., Mataga N., Murphy
N.P., Miyakawa T., Yamakawa K. Ts1Cje Down syndrome model mice exhibit
environmental stimuli-triggered locomotor hyperactivity and sociability
concurrent with increased flux through central dopamine and serotonin
metabolism. Exp Neurol. 2017,
293: 1-12. https://doi.org/10.1016/j.expneurol.2017.03.009
15. Ling K.H., Hewitt C.A., Tan
K.L., Cheah P.S., Vidyadaran S., Lai M.I., et
al. Functional transcriptome analysis of the postnatal brain of the Ts1Cje
mouse model for Down syndrome reveals global disruption of interferon-related
molecular networks. BMC Genomics 2014, 15: 624. https://doi.org/10.1186/1471-2164-15-624
16. Lim C.L., Ling K.H., Cheah
P.S. Isolation, cultivation and immunostaining of single myofibers- an improved
approach to study the behaviour of satellite cells. J Biol Methods 2018, 5:
e87. https://doi.org/10.14440/jbm.2018.219
17. Zammit P.S.,
Golding J.P., Nagata Y., Hudon V., Partridge T.A., Beauchamp J.R. Muscle
satellite cells adopt divergent fates. J Cell Biol 2004, 166:347-357.
https://doi.org/10.1083/jcb.200312007
18. Schlüter C.,
Duchrow M., Wohlenberg C., Becker M.H., Key G., Flad H.D., et al. The
cell proliferation-associated antigen of antibody Ki-67: a very large,
ubiquitous nuclear protein with numerous repeated elements, representing a new
kind of cell cycle-maintaining proteins. J Cell Biol 1993,
123: 513-522. https://doi.org/10.1083/jcb.123.3.513
19. Allen D.L., Roy R.R., Edgerton V.R. Myonuclear
domains in muscle adaptation and disease. Muscle
Nerve 1999, 22: 1350-1360. https://www.ncbi.nlm.nih.gov/pubmed/10487900
20. Brack A.S. Evidence that satellite cell decrement
contributes to preferential decline in nuclear number from large fibres during
murine age-related muscle atrophy. J Cell
Sci 2005, 118: 4813-4821. https://doi.org/10.1242/jcs.02602
21. Van der Meer S.F., Jaspers R.T., Degens H. Is the
myonuclear domain size fixed? J
Musculoskelet Neuronal Interact 2011, 11: 286-297. https://www.ncbi.nlm.nih.gov/pubmed/22130137
22. Neal A., Boldrin L., Morgan J.E. The satellite cell
in male and female, developing and adult mouse muscle: distinct stem cells for
growth and regeneration. PLoS ONE 2012, 7: e37950. https://doi.org/10.1371/journal.pone.0037950
23. Koopman R., Ly C.H., Ryall J.G. A metabolic link to
skeletal muscle wasting and regeneration. Front
Physiol 2014, 5: 32. https://doi.org/10.3389/fphys.2014.00032
24. Jang Y.C., Sinha M., Cerletti M., Dall'Osso C.,
Wagers A.J. Skeletal muscle stem cells: effects of aging and metabolism on
muscle regenerative function. Cold Spring Harb Symp Quant Biol 2011,
76: 101-111. https://doi.org/10.1101/sqb.2011.76.010652